NCT02274870View on ClinicalTrials.gov

Liposomal Bupivacaine for Post Operative Pain After Knee Replacement Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Post-operative Pain
Interventions
DRUG

Liposome Bupivacaine

Administered via local tissue infiltration around the knee joint

DRUG

Bupivacaine HCl

Administered via CFNB

Trial Locations (1)

11580

Franklin, Valley Stream

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
lead

Northwell Health

OTHER